Viewing nowCombinationEzetimibe/Atorvastatin Calcium Tablet 10/40 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Hubist Pharmaceutical Co., Ltd.

MFDS item code 202101428 · Approved 2021.02.18 · Insurance code 628801810
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication assists in lowering total cholesterol, LDL cholesterol, apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It helps to increase HDL cholesterol levels for maintaining a healthy lipid balance. Additionally, it is used alone or in conjunction with other lipid-lowering therapies to control cholesterol levels in patients with homozygous familial hypercholesterolemia. This medication is more effective when used alongside dietary measures and plays an important role in reducing cardiovascular disease risk due to dyslipidemia. It is important to verify secondary causes such as diabetes and hypothyroidism before administration and to take necessary precautions. This treatment is used to control blood lipid levels and improve cardiovascular health.
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended starting dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (at least 55%), a starting dose of 10/40mg once daily is recommended. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful.
This medication can cause serious muscle problems, so if sudden severe muscle pain or weakness occurs, consult a physician immediately. In particular, consider temporarily stopping or discontinuing this medication in cases of severe infections, hypotension, major surgery or trauma, severe metabolic abnormalities, or uncontrolled seizures. This medication should not be used in patients with allergies to its components, liver function issues, muscle diseases, pregnant or possibly pregnant women, nursing mothers, or patients taking certain hepatitis treatments. Additionally, patients with genetic conditions such as lactose intolerance should not take this medication. Patients with a history of alcohol addiction or liver disease, those with severe liver dysfunction, poor kidney function, hypothyroidism, a family history of muscle diseases, or previous muscle toxicity from similar medications, as well as elderly patients over 70 years of age, should use this medication with caution. Patients taking fibrate medications or those with severe muscle weakness also require careful monitoring. During the course of this medication, side effects such as muscle pain, abdominal pain, liver function abnormalities may occur, and it is important to regularly check liver function tests and muscle enzyme levels. If severe muscle pain or significant increases in muscle enzyme levels occur, the medication should be discontinued. Pregnant or nursing women should not use this medication, and women of childbearing age should use appropriate contraception while taking this medication. This medication is not recommended for children as safety and efficacy have not been established. When administered to the elderly, caution is required due to the risk of myopathy, although specific dose adjustments are not necessary. Patients with severe liver or kidney dysfunction should avoid using this medication, and those with liver function abnormalities should undergo regular testing. There is no specific antidote for overdose of this medication, so treatment and supportive care must be provided based on symptoms, and liver function and muscle enzyme levels should be monitored. This medication can interact with other drugs, so if you are taking other medications, it is essential to inform your doctor or pharmacist, especially when used with medications that affect liver metabolism or have effects on muscles. Caution should be exercised as dizziness may occur while driving or operating machinery. This medication should be kept out of the reach of children, and it is safer not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication must be kept in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.
White or off-white oblong film-coated tablets
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Hubist Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.